CDK2AP1 and squamous cell carcinoma: To analyze the clinical relevance of the selected CDK2AP1-antagonist miRs, we interrogated publicly available databases and validated the results by combining miR-FISH and CDK2AP1 IHC on tissue microarrays (TMAs) encompassing oral squamous carcinomas of the tongue.